Bruno François

1978–2025 年に発表

別表記
Bruno Francois
134
論文数
19,174
被引用数
71
h 指数
114
i10 指数

被引用数

Bruno François の年別被引用数1973 年: 被引用 1 件1976 年: 被引用 1 件1979 年: 被引用 2 件1980 年: 被引用 1 件1981 年: 被引用 2 件1982 年: 被引用 2 件1983 年: 被引用 2 件1984 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 1 件1998 年: 被引用 3 件1999 年: 被引用 3 件2000 年: 被引用 4 件2001 年: 被引用 1 件2002 年: 被引用 4 件2003 年: 被引用 4 件2004 年: 被引用 7 件2005 年: 被引用 12 件2006 年: 被引用 24 件2007 年: 被引用 30 件2008 年: 被引用 36 件2009 年: 被引用 38 件2010 年: 被引用 49 件2011 年: 被引用 57 件2012 年: 被引用 109 件2013 年: 被引用 101 件2014 年: 被引用 138 件2015 年: 被引用 143 件2016 年: 被引用 159 件2017 年: 被引用 169 件2018 年: 被引用 170 件2019 年: 被引用 472 件2020 年: 被引用 775 件2021 年: 被引用 894 件2022 年: 被引用 610 件2023 年: 被引用 494 件2024 年: 被引用 779 件2025 年: 被引用 469 件2026 年: 被引用 28 件2027 年: 被引用 1 件1974〜1975 年は被引用が無いため表示していません1977〜1978 年は被引用が無いため表示していません1985〜1986 年は被引用が無いため表示していません1990〜1991 年は被引用が無いため表示していません1996〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,552 件、この内訳の 16.1%中国: 引用元論文 885 件、この内訳の 9.2%フランス: 引用元論文 690 件、この内訳の 7.1%イギリス: 引用元論文 606 件、この内訳の 6.3%イタリア: 引用元論文 444 件、この内訳の 4.6%ドイツ: 引用元論文 403 件、この内訳の 4.2%カナダ: 引用元論文 387 件、この内訳の 4%オーストラリア: 引用元論文 344 件、この内訳の 3.6%スペイン: 引用元論文 344 件、この内訳の 3.6%オランダ: 引用元論文 318 件、この内訳の 3.3%ベルギー: 引用元論文 248 件、この内訳の 2.6%インド: 引用元論文 244 件、この内訳の 2.5%
0%16.1%その他 32.9%

分野

  • Medicine58.2%
  • Engineering15.5%
  • Biochemistry, Genetics and Molecular Biology9%
  • Immunology and Microbiology8.7%
  • Nursing1.6%
  • Energy1.4%
  • その他5.6%

トピック

  • Sepsis Diagnosis and Treatment9.4%
  • COVID-19 Clinical Research Studies4.3%
  • Microgrid Control and Optimization3.7%
  • Immune Response and Inflammation3.1%
  • Nosocomial Infections in ICU2.4%
  • Long-Term Effects of COVID-192.4%
  • その他74.7%

共著者

全論文

検索で開く
  1. The SOFA score—development, utility and challenges of accurate assessment in clinical trials

    著者: , , , - Critical Care 2019 被引用: 969

  2. Hydrocortisone in Severe Community-Acquired Pneumonia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Jourdain, M Leclerc, Carine Coffre, Hélène Bourgoin, Céline Lengellé, Caroline Caille-Fénérol, Bruno Giraudeau, Amélie Le Gouge - New England Journal of Medicine 2023 被引用: 434

  3. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michel Slama, O. Leroy, Gilles Capellier, Auguste Dargent, Tarik Hissem, Virginie Maxime, Éric Bellissant - New England Journal of Medicine 2018 被引用: 891

  4. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit

    著者: , , , , , , , , , , , - The Lancet Respiratory Medicine 2014 被引用: 1,277

  5. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial

    著者: , , , , , , , , , , , , , , , - JCI Insight 2018 被引用: 409

  6. Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2013 被引用: 795

  7. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2019 被引用: 370

  8. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julien Bohé, Gaëtan Plantefève, Saadalla Nseir, Jean‐Yves Lefrant, Xavier Monnet, Laurent Papazian, Christophe Vinsonneau, Jean‐Michel Constantin, Alexandre Mebazaa, Haikel Oueslati, D. Escudero, Fernando Martínez‐Sagasti, Enrique Piacentini, Paula Ramirez Galleymore, Thierry Dugernier, David Fagnoul, Isabelle Michaux, Allan Seibert, Matti Reinikainen, Thorbjørn Grøfte, Ignacio Martín‐Loeches, John G. Laffey - The Lancet Respiratory Medicine 2023 被引用: 74

  9. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Oliver, Olivier Barraud, Terramika Bellamy, Marc J. M. Bonten, Herman Goossens, Colin Reisner, Mark T. Esser, Hasan S. Jafri, The COMBACTE-MAGNET EVADE Study Group, Michael Joannidis, Walter Klimscha, Elisabeth De Waele, Jacques Devriendt, Vincent Huberlant, Pieter Depuydt, Sam Van Boxstael, Mladen Perić, Jasminka Kopić, Michal Hanauer, Tomas Hruby, Vladimír Šrámek, Petr Svoboda, Tomáš Vymazal, Martin Nováček, Djillali Annane, Jean‐Paul Mira, Bertrand Souweine, Pierre‐François Dequin, Ferhat Meziani, François Stéphan, Saadalla Nseir, Sébastien Gibot, Carole Schwebel, Gaëtan Plantefève, Jean‐Luc Diehl, Christian Richard, Christian Lamer, Kada Klouche, Samir Jaber, Epaminondas Zakynthinos, Georgios Filntisis, Spyros Zakynthinos, Antonia Koutsoukou, Georgios Saroglou, Charikleia Nikolaou, Glykeria Vlachogianni, Ioannis Pnevmatikos, Konstantinos Mandragos, Ildikó Krémer, Zsolt Dezso Rozgonyi, Zsuzsa Marjanek, Ignacio Martín‐Loeches, Pierre Singer, Vernon van Heerden, Yehuda Carmeli, Pedro Póvoa, Antonio Alvarez Seoane, Pedro Henrique de Moura, Filipe Gonzalez, Paula Ramírez, Antonio Torres Martí, Ricard Ferrer, Lorena Oteiza, D. Escudero, Enrique Piacentini, Paula Vera, Luis Tamayo, Miguel Angel Gonzalez Gallego, B. Suberviola Cañas, Iglesias Figueira ほか 18 名 - Critical Care 2022 被引用: 93

  10. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ludovic Gèrards, Phillipe Hantson, Virginie Montiel, Caroline Berghe, M Dujardin, Leslie Gielens, Suzanne Renard, Philippe G. Jorens, Pierre Asfar, Gaëtan Plantefève, Jacques Duranteau, Emmanuel Weiss, Constance Vuillard, Anne-Laure Fedou, Marine Goudelin, Bruno Evrard, Thomas Daix, Arnaud Desachy, Philippe Vignon, Anne-Aurore Duchambon, Ludmila Baudrillart, P Bourzeix, Alexandra Gay, Céline Prevost, Coralie Chalot, Isabelle Herafa, P. Engels, Martin Maëlle, Lila-Fariza Abeud, Laure Berton, Kamilė Čerlinskaitė‐Bajorė, Nicolas Deye, Marie-Céline Fournier, Tassadit Hadjam, Alexa Hollinger, Tuija Javanainen, Clément Jourdaine, Matthieu Legrand, Badr Louadah, Arthur Neuschwander, Raphaël Clère-Jehl, Julien Demiselle, Hamid Merdji, Alexandra Monnier, Emmanuelle Mercier, Stefan Kluge, Alexander Zarbock, Arthur R. H. van Zanten, Wytze Vermeijden, Tom Dormans - Intensive Care Medicine 2021 被引用: 92

  11. Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial

    著者: , , , , , , , , , , , , , , - Annals of Intensive Care 2023 被引用: 74

  12. Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 184

  13. Transient Stability Assessment and Enhancement of Grid-Forming Converters Embedding Current Reference Saturation as Current Limiting Strategy

    著者: , , , , - IEEE Transactions on Power Systems 2021 被引用: 261

  14. Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raphaël Cinotti, Pierre-Joachim Mahé, Dominique Demeure, Albane Soria, Delphine Flattrès, Gwenhaël Colin, Aihem Yehia, Jean-Claude Lacherade, Isabelle Vinatier, Christine Lebert, Yolaine Alcourt, Natacha Maguigneau, Vanessa Zinzoni, Marie-Anne Fally, Laurence Robin, Olivier Pajot, Emmanuelle Boitrou, Raphaël Favory, Julien Poissy, Anahita Rouze, Claire Delcourte, Yannick Rabouel, Julie Helms, Raphaël Clere-Jehl, Alexandra Monnier, Hamid Merdji, Samir Chenaf, Hayet Allam, Vincenta Franja, Xavier Wittebole, Philippe Hantson, Christine Colienne, Ludovic Gérard, Virginie Montiel, Diego Castanares Zapatero, Suzanne Renard, Marie France Dujardin, Caroline Berghe, Leslie Gielens - Intensive Care Medicine 2018 被引用: 109

  15. Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International Reports 2018 被引用: 107

  16. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre‐François Laterre, Didier Chochrad, Alain Dive, Frédéric Forêt, Marc A. Simon, Herbert Spapen, Jacques Créteur, Yves Bouckaert, Patrick Biston, Marc Bourgeois, Martin Nováček, Tomáš Vymazal, Petr Svoboda, Jan Pachl, Vladimír Šrámek, Michal Hanauer, Tomas Hruby, Martin Balík, Tomáš Suchý, Alain Lepape, Laurent Argaud, Frédéric Dailler, Arnaud Desachy, Christophe Guitton, Alain Mercat, Ferhat Meziani, Jean-Christophe Navellou, R. Robert, Bertrand Souweine, Jean‐Marc Tadié, Adel Maamar, Djillali Annane, Fabienne Tamion, Antoine Gros, Saad Nseir, Carole Schwebel, Gilles Francony, Jean‐Yves Lefrant, Francis Schneider, Matthias Gründling, J. Motsch, Lorenz Reill, Caroline Rolfes, Tobias Welte, Oliver A. Cornely, Frank Bloos, Maria Deja, Katrin Schmidt, Frank Wappler, Andreas Meier‐Hellmann, Apostolos Komnos, Vasileios Bekos, Vasilios Koulouras, Ioanna Soultati, Georgios Baltopoulos, Georgios Filntisis, Epaminondas Zakynthinos, Spyros Zakynthinos, Ioannis Pnevmatikos, Ildikó Krémer, Zoltán Szentkereszty, Ágnes Sárkány, Zsuzsa Marjanek, Pedro Henrique de Moura, Maria Consuelo Pintado Delgado, Juan Carlos Montejo González, Paula Ramírez, Antonio Torres Martí, Juan Carlos Valía, José A. Lorente ほか 6 名 - The Lancet Infectious Diseases 2021 被引用: 87

  17. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margot Vander Laenen, Marianne Vang, Philippe Vignon, Isabelle Vinatier, Sine Wichmann, Xavier Wittebole, Anne Louise Kjølbye, Derek C. Angus, for the SEPSIS-ACT Investigators - JAMA 2019 被引用: 140

  18. Enhancing sepsis biomarker development: key considerations from public and private perspectives

    著者: , , , , , , , , , , - Critical Care 2024 被引用: 79

  19. Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

    著者: , , , , , , , , , , , , , , , - Intensive Care Medicine 2020 被引用: 71

  20. Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angus Carter, D Friès, Philip Eller, Ludovic Gérard, Nicolas DeSchryver, Elisabeth Diltoer, Vincent Huberlant, Isabelle Michaux, Patrick M. Honoré, Tom Fivez, Christopher J. Doig, Gordon Wood, J. Gordon Boyd, Alexis F. Turgeon, Maj K. Kamper, Thomas Strøm, Sussanne Iversen, Hendrik Gammelager, Bodil Steen Rasmussen, Christoffer Sølling, Morten Hyllander Mæller, Thorbjoern Groefte, Nilanjan Dey, Ulf Gøttrup Pedersen, Mila Valkonen, Panu Uusalo, Ville Jalkanen, Ferhat Meziani, Jermie Lemarie, Gaëtan Plantefève, Konstantimos Bachoumas, Jean Louis Dufour, Anne-Laure Fedou, Pierre Asfar, Xavier Monnet, Christophe Vinsonneau, Sébastien Gibot, Christophe Guitton, Jean‐Pierre Quenot, Grégoire Müller, Jean Yves Lefrant, Emmanuelle Mercier, Alexandre Mebazaa, Andreas Kortgen, Sebastian Fichtner, Stefan Kluge, Gernot Marx, Ignatio Martin-Loeches, Bairbre McNicolas, Hidenobu Kamohara, Masahiro Harada, Takuo Nakagami, Shingo Adachi, Kohei Ota, Ryo Furuya, Ayumu Tsuruoka, Yasuaki Mizushima, Satoki Inoue, Pieter R. Tuinman, F Wim Roozendaal, Bert Beishuizen, Oscar Hoiting, Tom Dormans, Arthur R. H. van Zanten, Paul J. Young, Anthony P. Williams, Colin McArthur, Paweł Twardowski, Shay McGuinness, Ricard Ferrer ほか 21 名 - Intensive Care Medicine 2024 被引用: 67

  21. Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2023 被引用: 43

  22. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients

    著者: , , , , , , , , , , , , , - The Journal of Experimental Medicine 2020 被引用: 188

  23. Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration*

    著者: , , , , , , , , , , , , - Critical Care Medicine 2014 被引用: 110

  24. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandre Mebazaa - Critical Care 2021 被引用: 79